| payload |
{"created_at":"2026-04-10T14:13:04.518 {"created_at":"2026-04-10T14:13:04.518445+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:e46c93354dd9aeda","evidence_event_ids":["evt_3b80627272de"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRkJITFZzLUdiZmJ0SDdsZF8xRTUtcjFPM3FyXzNHdU93UXNzMkJTQVJDRVUySDV0UndEYkxWcXlaNFhab2VBYzhQMWVfajBhQWxVMW9JZndFdmluV0hOVmtENU5xYTBObmtPSVdCaVFRcTROaU55Z05ld1FwMmZERVItTVRidVNWdnVVSVluNWVOTjZkZ1FOLUZrZ2FNRFRScjZoR1d1ck8?oc=5","as_of":"2026-04-10T14:13:04.518445+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRkJITFZzLUdiZmJ0SDdsZF8xRTUtcjFPM3FyXzNHdU93UXNzMkJTQVJDRVUySDV0UndEYkxWcXlaNFhab2VBYzhQMWVfajBhQWxVMW9JZndFdmluV0hOVmtENU5xYTBObmtPSVdCaVFRcTROaU55Z05ld1FwMmZERVItTVRidVNWdnVVSVluNWVOTjZkZ1FOLUZrZ2FNRFRScjZoR1d1ck8?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_f53ac83bc80b14ea","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T14:20:17.002415+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRkJITFZzLUdiZmJ0SDdsZF8xRTUtcjFPM3FyXzNHdU93UXNzMkJTQVJDRVUySDV0UndEYkxWcXlaNFhab2VBYzhQMWVfajBhQWxVMW9JZndFdmluV0hOVmtENU5xYTBObmtPSVdCaVFRcTROaU55Z05ld1FwMmZERVItTVRidVNWdnVVSVluNWVOTjZkZ1FOLUZrZ2FNRFRScjZoR1d1ck8?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRkJITFZzLUdiZmJ0SDdsZF8xRTUtcjFPM3FyXzNHdU93UXNzMkJTQVJDRVUySDV0UndEYkxWcXlaNFhab2VBYzhQMWVfajBhQWxVMW9JZndFdmluV0hOVmtENU5xYTBObmtPSVdCaVFRcTROaU55Z05ld1FwMmZERVItTVRidVNWdnVVSVluNWVOTjZkZ1FOLUZrZ2FNRFRScjZoR1d1ck8?oc=5","source_event_id":"evt_3b80627272de","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"2ef53b0a09800bbf","kind":"ipo_calendar","published_at":"2026-04-10T13:56:16+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Avalyn Pharma","relevance":"primary","symbol":"AVLN","type":"company"},{"asset_class":"equity","name":"AVLN","relevance":"primary","symbol":"AVLN","type":"ticker"},{"asset_class":"other","name":"Seeking Alpha","relevance":"context","symbol":"","type":"publisher"}],"event_type":"listing","information_gaps":["The cleaned article text contains only CSS/page styling and does not include the article\u2019s substantive content.","No IPO specifics are provided in the available text (e.g., filing date, offering size, underwriters, expected pricing, exchange, or timeline).","No details are provided about the pulmonary fibrosis pipeline (e.g., lead asset, trial stage, or indications) beyond the general description in the headline.","Unclear whether AVLN is the current ticker or a referenced symbol in the article context."],"key_facts":["Signal headline states Avalyn Pharma begins the IPO process for its pulmonary fibrosis pipeline.","The headline associates the company/pipeline with ticker AVLN."],"numeric_claims":[],"primary_claim":"Avalyn Pharma began the IPO process for its pulmonary fibrosis pipeline (AVLN).","relevance_score":0.62,"sentiment":"neutral","source_quality":"high","summary":"The signal indicates that Avalyn Pharma has begun the IPO process for its pulmonary fibrosis pipeline, associated with ticker AVLN. The provided article text is not available beyond page styling, so no additional IPO details are extractable.","topics":["IPO process","pulmonary fibrosis pipeline","Avalyn Pharma","AVLN"]},"source":"Seeking Alpha","source_domain":"gstatic.com","summary":"Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline (AVLN) Seeking Alpha","tickers":["AVLN"],"title":"Avalyn Pharma Begins IPO Process For Pulmonary Fibrosis Pipeline (AVLN) - Seeking Alpha","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}... |